Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Protein Metrics Partner on Mass Spec Data Analysis Solutions

NEW YORK – Thermo Fisher Scientific and Protein Metrics said on Monday that they are have signed a non-exclusive comarketing agreement for their respective mass spectrometry data processing and analysis platforms for biopharmaceutical and proteomics applications.

The agreement includes Thermo Fisher's cloud-enabled Thermo Scientific Chromeleon CDS software, which provides automation and workflow support in order to increase productivity. It also involves Protein Metrics' Byos platform for protein characterization, which allows scientists to monitor posttranslational modifications and other quality attributes, and the firm's private-cloud Byosphere enterprise platform for automation, collaboration, and data management.

"Our collaboration with Protein Metrics allows us to leverage our shared expertise and seamlessly integrate our compliance-ready software capabilities to offer customers flexible tools that address these challenges and help meet their need for advanced technologies that analyze their mass spectrometry data," said Matt Hazlewood, Thermo Fisher's senior director of global chromatography data systems, in a statement.

"Integrating [our platform] with critical enterprise data systems, such as Chromeleon CDS, we aim to provide our mutual biopharmaceutical customers with intuitive, streamlined workflows to manage the burgeoning volume and complexity of analytical data with confidence," said Eric Carlson, president and CEO of Protein Metrics.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.